Your browser doesn't support javascript.
loading
DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.
Turnbull, Cynthia; Bones, Josiah; Stanley, Maurice; Medhavy, Arti; Wang, Hao; Lorenzo, Ayla May D; Cappello, Jean; Shanmuganandam, Somasundhari; Pandey, Abhimanu; Seneviratne, Sandali; Brown, Grant J; Meng, Xiangpeng; Fulcher, David; Burgio, Gaetan; Man, Si Ming; de Lucas Collantes, Carmen; Gasior, Mercedes; López Granados, Eduardo; Martin, Pilar; Jiang, Simon H; Cook, Matthew C; Ellyard, Julia I; Athanasopoulos, Vicki; Corry, Ben; Canete, Pablo F; Vinuesa, Carola G.
Affiliation
  • Turnbull C; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Bones J; Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Stanley M; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Medhavy A; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Wang H; The Francis Crick Institute, London, UK.
  • Lorenzo AMD; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Cappello J; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Shanmuganandam S; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Pandey A; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Seneviratne S; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Brown GJ; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Meng X; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Fulcher D; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Burgio G; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Man SM; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • de Lucas Collantes C; Nephrology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Gasior M; Hematology Department, Hospital Universitario La Paz, Madrid, Spain.
  • López Granados E; Clinical Immunology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Martin P; Center for Biomedical Network Research on Rare Diseases, Madrid, Spain.
  • Jiang SH; Lymphocyte Pathophysiology in Immunodeficiencies Group, La Paz Institute for Health Research, Madrid, Spain.
  • Cook MC; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
  • Ellyard JI; Centro de Investigacion Biomedica En Rad, Madrid, Spain.
  • Athanasopoulos V; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Corry B; Cambridge Institute for Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, UK.
  • Canete PF; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Vinuesa CG; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
Sci Adv ; 9(49): eadi9566, 2023 12 08.
Article in En | MEDLINE | ID: mdl-38055819
ABSTRACT
Autosomal dominant loss-of-function (LoF) variants in cytotoxic T-lymphocyte associated protein 4 (CTLA4) cause immune dysregulation with autoimmunity, immunodeficiency and lymphoproliferation (IDAIL). Incomplete penetrance and variable expressivity are characteristic of IDAIL caused by CTLA-4 haploinsufficiency (CTLA-4h), pointing to a role for genetic modifiers. Here, we describe an IDAIL proband carrying a maternally inherited pathogenic CTLA4 variant and a paternally inherited rare LoF missense variant in CLEC7A, which encodes for the ß-glucan pattern recognition receptor DECTIN-1. The CLEC7A variant led to a loss of DECTIN-1 dimerization and surface expression. Notably, DECTIN-1 stimulation promoted human and mouse regulatory T cell (Treg) differentiation from naïve αß and γδ T cells, even in the absence of transforming growth factor-ß. Consistent with DECTIN-1's Treg-boosting ability, partial DECTIN-1 deficiency exacerbated the Treg defect conferred by CTL4-4h. DECTIN-1/CLEC7A emerges as a modifier gene in CTLA-4h, increasing expressivity of CTLA4 variants and acting in functional epistasis with CTLA-4 to maintain immune homeostasis and tolerance.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lectins, C-Type / Haploinsufficiency Limits: Animals / Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lectins, C-Type / Haploinsufficiency Limits: Animals / Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country: Australia